Dr Ferhana Hashem BA, MA, PhD, PGCE
Research Fellow, ICAP Internship Programme Leader and NIHR RDS SE Research Adviser
- 01227 824887
I am currently working on an Economic and Social Research Council (ESRC) funded project with Professor Michael Calnan (PI) looking at the issue of uncertainty in NICE (National Institute for Health & Care Excellence) single technological appraisals. This work involves working closely with the NICE technological appraisals teams and appraisal committees to investigate how decisions are made in funding new drug therapies.
I have been trained in conducting sociological research and specialise in qualitative and mixed methods approaches. I have experience in working on projects in health promotion research focusing upon vulnerable people (older people), social marketing and health promotion, physical activity in young girls and teenage pregnancy in looked after young people.
My own research focuses upon the language and translation support needs of minority ethnic groups in Britain – in particular, in relation to accessing services including healthcare in the NHS, overcoming barriers to treatment and improving language services to minority ethnic patients. I have a broader interest in research on the identity issues of minority ethnic groups/mixed race people in Britain. I have also published work on the health and language needs of minority ethnic groups and, more generally, wider sociological issues on racial and ethnic identity.
I joined the University of Kent in 2006. I previously worked at Anglia Ruskin University (2004-2006) at the Department of Humanities and Social Sciences for a two year post-doctural research. Previously, I taught social sciences at the University of Durham (2001-2004) and the University of Sunderland (2000-2003).
I completed my BA in Politics from the School of Oriental and African Studies (1997) and completed my MA in History from King’s College London. I received a PhD stipend from the University of Sunderland (1999-2003) to undertake my PhD research in Political Sociology.
Previous Research includes:
Economic and Social Research Council (ESRC) on the “Ethnic options of mixed-race people in Britain‟ (PI: Mr Peter Aspinall; CO: Dr Miri Song & second CO: Dr Ferhana Hashem) (March 2006-May 2008; grant reference: RES-000-23-1507) (£155,405.73)
Nuffield Foundation Small Social Science Grant “What kind of language services should public authorities provide to minority ethnic groups: the case of Bangladeshis in London‟ (PI: Dr Ferhana Hashem; CI: Mr Peter Aspinall) (February 2008-November 2009) (£9,025)
I have been teaching for the School for Social Policy, Sociology and Social Research (SSPSSR) on two modules; for the undergraduate module SO537 (Racism) and a postgraduate module SO884 (Race, Difference and Belonging). I am currently providing supervision for two MA students for the School.back to top
Also view these in the Kent Academic Repository
Evaluation of the benefits of the British Lung Foundation's 'Breathe Easy' peer support network. ‘Integrated Breathe Easy’ is a two year evaluation undertaken on behalf of the British Lung Foundation (BLF) funded by the Cabinet Office through Nesta. It will assess whether integrating Breathe Easy groups into local respiratory care pathways results in better health and well-being outcomes for patients and carers. More than 230 BLF ‘Breathe Easy’ voluntary patient groups meet monthly across Britain. They aim to develop knowledge and increase self-management levels among those with long term lung disease including COPD, asthma and sarcoidosis. They offer support from health professionals and social activities. The study compares three cohorts to measure impact and assess outcomes: groups not integrated into the NHS care pathway new groups which are integrated control group - patients not attending Breathe Easy, but would be willing to. The focus is on patient understanding and self-help. Data collection in year one will explore patient self-efficacy levels, and their knowledge of where to seek help and advice. Carers will also be questioned about their confidence and burden of care. Year two will focus on cost effectiveness of the groups. Rowena Merritt leads and project manages the CHSS research team which includes Research Fellow Ferhana Hashem, Health Economist Olena Nizalova and Statistician Tracy Higgins. Start date: 01/04/2014 End date: 30/04/2016 Funder: British Lung Foundation Funding: £74,725
Managing uncertainty within NICE technological appraisals: the nature and impact of the 'social features' of decision-making
The National Health Service faces significant challenges in trying to meet people's health needs with very limited resources. While new drugs are made available which mean serious conditions can now be treated, spending money on these (sometimes expensive) products will mean that other services have to be sacrificed. NICE (the National Institute for Health and Clinical Excellence) seeks to ensure that the NHS’s limited resources are spent on drugs which are cost effective - good value. Such cost effectiveness decisions are especially important as the NHS seeks to function on increasingly constrained resources. The cost-effectiveness decisions made by NICE, known as 'technological appraisals', would appear to be highly objective and rational. Data about the cost and typical impact of the drug are collected and a decision is duly reached. Under more detailed inspection however, things are not so straightforward. There appears to be much uncertainty throughout the decision-making process - for example in terms of: whether scientific assessments of the effectiveness of a drug are relevant in everyday clinical situations; what we consider 'quality of life' to really mean; or how we make decisions about a drug's likely long term, wide-spread impact from relatively small amounts of data. Moreover, the committee members who must decide whether a drug is cost effective or not cannot be experts in every aspect of information which is presented to them. Hence, they must listen to the opinions of experts in various fields and make decisions as to how much they should heed their assessments. Some of the relevant information will also be provided by the drug manufacturer(s) or patient groups, these representatives may have other interests besides helping NICE make the most equitable decision. This research explores the ways in which various people (N=40) involved in NICE appraisal decisions, not least committee members, deal with these multiple levels of uncertainty. The key objectives are to explore the different approaches used for dealing with uncertainty and the impact of these methods on decision outcomes. The research is follow three specific drugs through the technological appraisal process - analysing the various documents produced by NICE which relate to these appraisals, observing the way evidence is presented and discussed at ‘open’ and ‘closed’ sessions of committee meetings, and interviewing a range of key actors and committee members to better understand their attitudes, beliefs and actions. By comparing the data produced from these three sources - documents, observations, interviews - we aim to develop an understanding of how uncertainty is perceived, considered, presented and tackled within these drug appraisals. From an institutional point of view this would enable more robust decision-making and therefore a more efficient use of NHS resources. At an ethical level this knowledge would help refine appraisals to assure more equitable outcome. The study is led by Professor Michael Calnan of SSPSSR and also includes a contribution from Dr Patrick Brown from the University of Amsterdam. Start date: 01/09/2011 End date: 31/08/2014 Funder: ESRC Funding: £48,679
Postgraduate taught programmes for Health Leaders
In collaboration with Kent Business School, CHSS is developing the following bespoke Postgraduate taught programmes in International Healthcare Leadership and Management, for Managers working within European and Canadian health systems. Masters (MSc) in International Healthcare Leadership and Management Postgraduate Diploma International Healthcare Leadership and Management Postgraduate Certificate in International Healthcare Leadership and Management Global pharmaceutical company Abbvie are funding the set-up and development of the course programmes through their European Office in Paris. Kent Business School are providing expertise in management, leadership and marketing. CHSS will deliver the student-funded courses to run next year and beyond 2016, through flexible learning with time spent on Kent University’s Canterbury campus. The programmes address new approaches to health care management within and across NHS, EU and other global health systems. They will meet an identified need for learning focused on skills for health leaders to effectively manage a changing health environment and ever-increasing demands on health systems. Developed countries are facing the challenge of adapting to approaches to health care that focus on how services are organised and managed. Organisations are tending to become smaller with flatter structures and as they cope with more complex delivery settings, they must adopt collaborative, integrated working. Learning from the modules will be immediately transferable to the workplace. The programmes complement and develop recent CHSS work supporting healthcare managers in adapting to structural changes and shifts in health care delivery. CHSS Research Fellows Ferhana Hashem and Rowena Merritt are leading on module development and learning objectives, supported by Research Assistant Catherine Marchand. Start date: 01/08/2015 End date: ongoing Funder: AbbVie Biopharmaceuticals Funding: £41,711
EPOP: Development of a peri-operative isometric-resistance exercise intervention programme for patients undergoing elective abdominal and thoracic surgery for cancer
A two phase, three year development study of an isometric exercise programme to benefit patients who have undergone abdominal and thoracic cancer surgery. Cancer surgery is associated with risk of some loss of physical function and muscle wastage. Isometric exercise has long been established as effective in increasing muscle strength. Phase one will consist of patient focus groups and an online Delphi survey which will develop the exercise intervention and identify suitable functional outcome measures. Phase two will be a mini pilot and evaluation (effectiveness and cost effectiveness) study, based on two groups randomised to either intervention or usual treatment. The programme will be delivered in hospital but the nature of the exercises means that patients can continue at home after discharge.The programme needs little equipment and space, so can be performed when patients are bed-bound in hospital or at home. Start date: 02/03/2015 End date: 31/03/2018 Funder: NIHR via Maidstone and Tunbridge Wells NHS Trust Funding: £76,130
Optimum Hospice at Home services for end of life care
What are the features of Hospice at Home models that work, for whom, and under what circumstances? Offering a choice about where people receive care at the end of life is central to UK policy and the numbers of people wishing to die at home is increasing. There are a range of “Hospice at Home” (HAH) services and most operate within non NHS settings, but are funded to provide NHS specialist care. Gaps exist in the evidence around what works best in terms of outcomes. This three year project, funded by the NIHR Health Services and Delivery Research Programme is a collaboration between CHSS, Pilgrims Hospices East Kent, and the Universities of Cambridge and Surrey. The team will conduct a realist evaluation of a range of UK ‘Hospice at Home’ service models to understand their impact on patients and carers, and identify which features work for whom, under what circumstances. A project PPI (patient and public involvement) advisory group will advise on sensitive approaches to working with bereaved people. The project team includes two lay members. The project incorporates three phases. Phase 1: A national telephone survey of all HAH services in the UK on funding, staffing levels and roles, extent of service and care, local demographics etc. Data will inform the design of a typology of services, patterns and models using a CMOc framework (Context-Mechanism-Outcome configuration). 1-2 case studies per service model will receive in-depth investigation. Phase 2: An economic evaluation to compare the costs of delivering services in the different models and assess which models are likely to lead to the best outcomes and represent best value for money. Phase 3: Stakeholder validation Two national workshops will gather feedback on the implications of data findings from HAH providers, local health service planners and service user representatives. Guidelines will be developed to help plan HAH services in the future. Dissemination strategy includes a project report, conference presentations and peer reviewed journal articles aimed at professional audiences. Start date: 01/02/17 End date: 31/01/20 Funder: NIHR Health Services and Delivery Research programme. 14/197/44 HS&DR Researcher-led Funding: £760,162 Project team: CI: Dr Claire Butler Contractor: University of Kent Co-investigators: CHSS, Uni of Kent: Prof Tricia Wilson, Dr Ferhana Hasham, University of Cambridge: Dr Stephen Barclay University of Surrey: Prof Heather Gage, Dr Peter Williams Pilgrims Hospices East Kent: Ms Charlotte Brigden NHS England: Prof Bee Wee, (Nat Clin Dir. End of Life Care/Assoc Prof Uni of Oxford) Nat Assn for Hospice at Home (NAHH): Ms Kay Greene, Chair & Trustee PPI/Service users: Ms Mary Goodwin, Mr Graham Silsbury
The Ethnic Options of Mixed Race People in Britain
The research will explore the ethnic options of young (18-25) mixed race people attending colleges of further education and universities in England.The project investigates the range of identity choices potentially available to mixed-race young people in Britain. Together with Ferhana Hashem, also from CHSS, they are undertaking the largest and most detailed study of its kind in the UK and which will supply the research community, census agencies and the providers of educational, health and other public services with a comprehensive insight into the personal, group and political dimensions of mixed-race identities. There are two components to the study: (i) A questionnaire survey of around 300 students who identify as mixed race (or are of mixed race heritage); (ii) in-depth interviews with a sample of 60-80. Start date: 01/03/2006 End date: 29/02/2008 Funder: Economic and Social Research Council Funding: £156,000 Publication: The ethnic options of ‘mixed race’ people in Britain - Full Research Report
Director of Studies - Applied Health Research - MSc
Intercalated BSc in Management in Primary Careback to top